ASN Names Next Editor-in-Chief of CJASN

ASN has named Rajnish Mehrotra, MD, FASN, as CJASN Editor-in-Chief effective January 1, 2017. He will serve a six-year term.

“It’s an honor to have the opportunity to serve as Editor-in-Chief of the nation’s leading clinical nephrology research journal," said Mehrotra, Head of Nephrology at Harborview Medical Center in Seattle, Washington, a Professor of Medicine at the University of Washington and an investigator at the Kidney Research Institute. “I will build on the work done by Bill Bennett and Gary Curhan by preserving the core mission of communicating the most important advances in clinical research, including innovations in research methods and care delivery, putting these advances in context for future research directions and patient care, and becoming an important voice influencing innovation, research funding and prioritization, and public policy, including delineating the value nephrologists provide in promoting population health.”

Dr. Mehrotra’s own research, which has focused on topics including the comparative effectiveness of dialysis therapies, patient-reported outcomes, and ethnic disparities in chronic kidney disease, has at times been published in the journal he will soon lead. Learn more about Dr. Mehrotra here.

Category:
Subcategory:
Article Image:
Body:

ASN has named Rajnish Mehrotra, MD, FASN, as CJASN Editor-in-Chief effective January 1, 2017. He will serve a six-year term.

“It’s an honor to have the opportunity to serve as Editor-in-Chief of the nation’s leading clinical nephrology research journal," said Mehrotra, Head of Nephrology at Harborview Medical Center in Seattle, Washington, a Professor of Medicine at the University of Washington and an investigator at the Kidney Research Institute. “I will build on the work done by Bill Bennett and Gary Curhan by preserving the core mission of communicating the most important advances in clinical research, including innovations in research methods and care delivery, putting these advances in context for future research directions and patient care, and becoming an important voice influencing innovation, research funding and prioritization, and public policy, including delineating the value nephrologists provide in promoting population health.”

Dr. Mehrotra’s own research, which has focused on topics including the comparative effectiveness of dialysis therapies, patient-reported outcomes, and ethnic disparities in chronic kidney disease, has at times been published in the journal he will soon lead. Learn more about Dr. Mehrotra here.